Carregant...

The effects of AST-120 on chronic kidney disease progression in the United States of America: a post hoc subgroup analysis of randomized controlled trials

BACKGROUND: The orally administered spherical carbon adsorbent AST-120 is used on-label in Asian countries to slow renal disease progression in patients with progressive chronic kidney disease (CKD). Recently, two multinational, randomized, double-blind, placebo-controlled, phase 3 trials (Evaluatin...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Nephrol
Autors principals: Schulman, Gerald, Berl, Tomas, Beck, Gerald J., Remuzzi, Giuseppe, Ritz, Eberhard, Shimizu, Miho, Shobu, Yuko, Kikuchi, Mami
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2016
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5045594/
https://ncbi.nlm.nih.gov/pubmed/27716149
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12882-016-0357-9
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!